A new study published in the journal of Annals of Internal Medicine revealed that serial measurement of N-terminal pro–B-type ...
Developing or continuing to experience heart stress over time is associated with increased risks for cardiovascular disease ...
Background Diagnosing heart failure with preserved ejection fraction (HFpEF) can be challenging because natriuretic peptide (NP) plasma levels and diastolic function parameters during rest ...
For community-dwelling older adults, longitudinal changes in N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentrations (heart stress [HS]) may improve risk stratification for cardiovascular ...
Diagnostic thresholds of N-terminal prohormone of brain natriuretic peptide (NT-proBNP) for heart failure with preserved ejection fraction (HFpEF) in ambulatory patients with chronic dyspnearequire ...
The Catalyst proBNP test brings lab-quality cardiac biomarker results into the exam room, aiming to close a diagnostic gap that leaves a large share of heart disease in companion animals undetected.
Dublin, April 15, 2024 (GLOBE NEWSWIRE) -- The "BNP And NTproBNP Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F" report has been added to ResearchAndMarkets.com's ...
Two out of five blood biomarkers tested most accurately distinguished adults with PH from healthy individuals, a study found.
NT-proBNP is a cornerstone biomarker in the diagnosis and management of heart failure. Despite its widespread use, important biological and analytical challenges remain. One of the most significant is ...
Increased adjusted absolute risks for total CVD, all-cause mortality seen with incident and sustained versus persistently heart stress-free ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results